205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Revenue growth under 50% of AMD's 12.73%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.44%
Gross profit growth under 50% of AMD's 25.60%. Michael Burry would be concerned about a severe competitive disadvantage.
10.06%
EBIT growth below 50% of AMD's 133.34%. Michael Burry would suspect deeper competitive or cost structure issues.
9.27%
Operating income growth under 50% of AMD's 151.89%. Michael Burry would be concerned about deeper cost or sales issues.
-7.68%
Negative net income growth while AMD stands at 190.95%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.85%
Negative EPS growth while AMD is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.00%
Negative diluted EPS growth while AMD is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-5.29%
Share reduction while AMD is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.04%
Reduced diluted shares while AMD is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
8.69%
Dividend growth of 8.69% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-58.68%
Negative OCF growth while AMD is at 13.99%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-152.53%
Negative FCF growth while AMD is at 20.12%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
43.68%
10Y revenue/share CAGR under 50% of AMD's 99.94%. Michael Burry would suspect a lasting competitive disadvantage.
-12.20%
Negative 5Y CAGR while AMD stands at 17.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
14.04%
3Y revenue/share CAGR under 50% of AMD's 92.42%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
322.80%
10Y OCF/share CAGR under 50% of AMD's 944.86%. Michael Burry would worry about a persistent underperformance in cash creation.
57.02%
5Y OCF/share CAGR 1.25-1.5x AMD's 45.81%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
29.13%
3Y OCF/share CAGR under 50% of AMD's 227.69%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2488.56%
Net income/share CAGR above 1.5x AMD's 618.49% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
66.59%
5Y net income/share CAGR above 1.5x AMD's 30.96%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
205.05%
Below 50% of AMD's 1322.03%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
261.53%
10Y equity/share CAGR above 1.5x AMD's 55.29%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
211.41%
Positive 5Y equity/share CAGR while AMD is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
147.24%
3Y equity/share CAGR above 1.5x AMD's 4.62%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
16.57%
Stable or rising dividend while AMD is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
38.50%
Stable or rising mid-term dividends while AMD is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
2.24%
3Y dividend/share CAGR of 2.24% while AMD is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.10%
Our AR growth while AMD is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
4.81%
Inventory growth well above AMD's 3.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.45%
Asset growth above 1.5x AMD's 5.95%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
27.76%
BV/share growth above 1.5x AMD's 11.07%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.41%
We’re deleveraging while AMD stands at 4.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
18.99%
R&D growth drastically higher vs. AMD's 6.86%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-18.83%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.